Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Vox Sang. 2022 Oct;117(10):1187-1194. doi: 10.1111/vox.13335. Epub 2022 Jul 19.
Thrombocytopenia is common among sepsis patients. Platelet transfusions are frequently administered to increase platelet counts, but their clinical impacts remain unclear in sepsis-induced thrombocytopenia. The goal of this study was to explore the association between platelet transfusion and mortality in patients with sepsis-induced thrombocytopenia.
The study was based on the Medical Information Mart for Intensive Care (MIMIC) III database. Septic patients with severe thrombocytopenia (a platelet count ≤ 50/nl) were included in the study and were divided into two groups: a platelet transfusion group (PT group) and a no platelet transfusion group (NPT group). The primary outcome was in-hospital mortality, and the secondary outcomes were the length of intensive care unit (ICU) stay (LOS-ICU) and 90-day mortality. Propensity score matching multivariable logistic regression was used to reduce the imbalance.
A total of 1733 patients were included: 296 patients were included in the PT group and 1437 patients were included in the NPT group. After propensity score matching, 296 paired patients constituted each group. Crude hospital mortality was significantly higher in the PT group than in the NPT group (145 [48.99%] vs. 567 [39.46%], p = 0.002). In the extended multivariable logistic models for hospital mortality, the odds ratio (OR) of receiving a platelet transfusion was consistently significant in all six models (OR range, 1.340-1.525, p < 0.05 for all). In the following subgroups, platelet transfusion was associated with increased in-hospital mortality: age > 60 years; sex: female; sequential organ failure assessment score ≤8; simplified acute physiology score ≤ 47; platelet count >29/nl and the complication of congestive heart failure. However, there were no significant differences in the 90-day mortality rate (170 [57.43%] vs. 741 [51.57%], p = 0.066) or the LOS-ICU (5.84 [2.68-11.78] vs. 4.94 [2.18-12.72], p = 0.442) between the two groups. All these results remained stable after adjustment for confounders and in the comparisons after propensity score matching.
The propensity score-matched analysis showed that platelet transfusion was associated with increased in-hospital mortality in septic patients with severe thrombocytopenia (a platelet count ≤ 50/nl). However, it was not associated with 90-day mortality or the length of ICU stay.
血小板减少症在脓毒症患者中很常见。常进行血小板输注以增加血小板计数,但在脓毒症相关血小板减少症中,其临床影响仍不清楚。本研究的目的是探讨血小板输注与脓毒症相关血小板减少症患者死亡率之间的关系。
本研究基于医疗信息互操作资源库(MIMIC)III 数据库。纳入严重血小板减少症(血小板计数≤50/nl)的脓毒症患者,并将其分为两组:血小板输注组(PT 组)和未进行血小板输注组(NPT 组)。主要结局为院内死亡率,次要结局为重症监护病房(ICU)住院时间(LOS-ICU)和 90 天死亡率。采用倾向评分匹配多变量逻辑回归来减少不平衡。
共纳入 1733 例患者:PT 组 296 例,NPT 组 1437 例。进行倾向评分匹配后,每组匹配 296 对患者。PT 组患者的院内死亡率明显高于 NPT 组(145[48.99%]比 567[39.46%],p=0.002)。在用于院内死亡率的扩展多变量逻辑模型中,接受血小板输注的比值比(OR)在所有六个模型中均具有统计学意义(OR 范围,1.340-1.525,p<0.05)。在以下亚组中,血小板输注与院内死亡率增加相关:年龄>60 岁;性别:女性;序贯器官衰竭评估评分≤8;简化急性生理学评分≤47;血小板计数>29/nl 和充血性心力衰竭并发症。然而,两组之间的 90 天死亡率(170[57.43%]比 741[51.57%],p=0.066)或 ICU 住院时间(5.84[2.68-11.78]比 4.94[2.18-12.72],p=0.442)均无显著差异。在调整混杂因素和倾向评分匹配后的比较后,所有这些结果均保持稳定。
倾向评分匹配分析表明,血小板输注与严重血小板减少症(血小板计数≤50/nl)的脓毒症患者的院内死亡率增加有关。然而,它与 90 天死亡率或 ICU 住院时间无关。